Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7088134 | 7937362 | I | 7088134-7 | 20100922 | 20101012 | 20101028 | EXP | AE10-0042 | ANCHEN PHARMACEUTICALS, INC. | 29 | YR | M | N | 154.6 | LBS | 20101022 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7088134 | 1015062829 | SS | DUTASTERIDE/TAMSULOSIN HCL | 2 | D | D | P00410130 | 20100408 | 022460 | ||
| 7088134 | 1015174217 | PS | JALYN | 1 | ORAL | 0.5 MG/0.4 MG, ORAL | D | D | 0ZP8188 | 20120401 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7088134 | 1015062829 | BENIGN PROSTATIC HYPERPLASIA |
| 7088134 | 1015174217 | BENIGN PROSTATIC HYPERPLASIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7088134 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 7088134 | ABDOMINAL PAIN |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 7088134 | SDY |
| 7088134 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7088134 | 1015174217 | 20100912 |